1 - 25 of 29 results for author:"Theodorou I." in Literature citations
Results Customize
› Repeat search in UniProtKB (135)
| Genome-wide association study identifies variants associated with progression of liver fibrosis from HCV infection. International Hepatitis C Genetics Consortium Gastroenterology 143:1244-52.e1-12(2012) · Mapped (15) |
| Analysis of IL28B variants in an Egyptian population defines the 20 kilobases minimal region involved in spontaneous clearance of hepatitis C virus. Pedergnana V., Abdel-Hamid M., Guergnon J., Mohsen A., Le Fouler L., Theodorou I., Mohamed M.K., Fontanet A., Plancoulaine S., Abel L. PLoS ONE 7:e38578-e38578(2012) · Mapped (1) |
| IL28B alleles associated with poor hepatitis C virus (HCV) clearance protect against inflammation and fibrosis in patients infected with non-1 HCV genotypes. Bochud P.Y., Bibert S., Kutalik Z., Patin E., Guergnon J., Nalpas B., Goossens N., Kuske L., Mullhaupt B., Gerlach T. et al. Hepatology 55:384-394(2012) · Mapped (1) |
| Genome-wide association study identifies new HLA class II haplotypes strongly protective against narcolepsy. Hor H., Kutalik Z., Dauvilliers Y., Valsesia A., Lammers G.J., Donjacour C.E., Iranzo A., Santamaria J., Peraita Adrados R., Vicario J.L. et al. Nat. Genet. 42:786-789(2010) · Mapped (485) |
| Is long-term virological response related to CCR5 Delta32 deletion in HIV-1-infected patients started on highly active antiretroviral therapy? Laurichesse J.J., Taieb A., Capoulade-Metay C., Katlama C., Villes V., Drobacheff-Thiebaud M.C., Raffi F., Chene G., Theodorou I., Leport C. HIV Med. 11:239-244(2010) · Mapped (22) |
| Restless legs syndrome, rapid eye movement sleep behavior disorder, and hypersomnia in patients with two parkin mutations. Limousin N., Konofal E., Karroum E., Lohmann E., Theodorou I., Durr A., Arnulf I. Mov. Disord. 24:1970-1976(2009) · Mapped (17) |
| Distinct genetic loci control plasma HIV-RNA and cellular HIV-DNA levels in HIV-1 infection: the ANRS Genome Wide Association 01 study. Dalmasso C., Carpentier W., Meyer L., Rouzioux C., Goujard C., Chaix M.L., Lambotte O., Avettand-Fenoel V., Le Clerc S., de Senneville L.D. et al. PLoS ONE 3:e3907-e3907(2008) · Mapped (4) |
| Impact of renin-angiotensin-aldosterone system genes on the treatment response of patients with hypertension and metabolic syndrome. Milionis H.J., Kostapanos M.S., Vakalis K., Theodorou I., Bouba I., Kalaitzidis R., Georgiou I., Elisaf M.S., Siamopoulos K.C. J Renin Angiotensin Aldosterone Syst 8:181-189(2007) · Mapped (10) |
| Identification of the CCR5-Delta32 HIV resistance allele and new mutations of the CCR5 gene in different Tunisian populations. Jlizi A., Edouard J., Fadhlaoui-Zid K., Frigi S., Debre P., Slim A., Theodorou I., El Gaaied A.B., Carpentier W. Hum. Immunol. 68:993-1000(2007) · UniProtKB (9) · Mapped (21) |
| CCR5Delta32 59537-G/A promoter polymorphism is associated with low translational efficiency and the loss of CCR5Delta32 protective effects. Jin Q., Agrawal L., Meyer L., Tubiana R., Theodorou I., Alkhatib G. J. Virol. 82:2418-2426(2008) · Mapped (22) |
| Polymorphisms in CCR5 chemokine receptor gene in Japan. Liu H., Nakayama E.E., Theodorou I., Nagai Y., Likanonsakul S., Wasi C., Debre P., Iwamoto A., Shioda T. Int. J. Immunogenet. 34:325-335(2007) · Mapped (24) |
| CCR5Delta32 protein expression and stability are critical for resistance to human immunodeficiency virus type 1 in vivo. Agrawal L., Jin Q., Altenburg J., Meyer L., Tubiana R., Theodorou I., Alkhatib G. J. Virol. 81:8041-8049(2007) · Mapped (22) |
| Wild type and H43Y variant of human TRIM5alpha show similar anti-human immunodeficiency virus type 1 activity both in vivo and in vitro. Nakayama E.E., Carpentier W., Costagliola D., Shioda T., Iwamoto A., Debre P., Yoshimura K., Autran B., Matsushita S., Theodorou I. Immunogenetics 59:511-515(2007) · Mapped (3) |
| A natural CCL5/RANTES variant antagonist for CCR1 and CCR3. Capoulade-Metay C., Ayouba A., Kfutwah A., Lole K., Petres S., Dudoit Y., Deterre P., Menu E., Barre-Sinoussi F., Debre P. et al. Immunogenetics 58:533-541(2006) · UniProtKB (1) · Mapped (3) |
| Polymorphism in the proximal promoter region of the perforin gene and its impact on the course of HIV infection. McIlroy D., Meyer L., Dudoit Y., Samri A., Delfraissy J.F., Autran B., Debre P., Theodorou I. Int. J. Immunogenet. 33:73-79(2006) · Mapped (2) |
| Causal pathways of the effects of age and the CCR5-Delta32, CCR2-64I, and SDF-1 3'A alleles on AIDS development. Geskus R.B., Meyer L., Hubert J.B., Schuitemaker H., Berkhout B., Rouzioux C., Theodorou I.D., Delfraissy J.F., Prins M., Coutinho R.A. J. Acquir. Immune Defic. Syndr. 39:321-326(2005) · Mapped (26) |
| Biochemical and HIV-1 coreceptor properties of K26R, a new CCR5 Variant in China's Sichuan population. Ma L., Dudoit Y., Tran T., Xing H., Chen J., Pancino G., Bismuth G., Debre P., Shao Y., Theodorou I. et al. J. Acquir. Immune Defic. Syndr. 39:38-43(2005) · UniProtKB (1) · Mapped (21) |
| New CCR5 variants associated with reduced HIV coreceptor function in southeast Asia. Capoulade-Metay C., Ma L., Truong L.X., Dudoit Y., Versmisse P., Nguyen N.V., Nguyen M., Scott-Algara D., Barre-Sinoussi F., Debre P. et al. |
| Deleterious genetic influence of CX3CR1 genotypes on HIV-1 disease progression. Faure S., Meyer L., Genin E., Pellet P., Debre P., Theodorou I., Combadiere C. J. Acquir. Immune Defic. Syndr. 32:335-337(2003) · Mapped (1) |
| Frequency analysis of the CCR5delta32 mutation in patients with brucellosis. Skendros P., Boura P., Tsantas N., Debre P., Theodorou I. Scand. J. Infect. Dis. 34:944-946(2002) · Mapped (22) |
| Effects of CCR5-Delta32 and CCR2-64I alleles on HIV-1 disease progression: the protection varies with duration of infection. Mulherin S.A., O'Brien T.R., Ioannidis J.P., Goedert J.J., Buchbinder S.P., Coutinho R.A., Jamieson B.D., Meyer L., Michael N.L., Pantaleo G. et al. AIDS 17:377-387(2003) · Mapped (24) |
| Protective effect of interleukin-4 -589T polymorphism on human immunodeficiency virus type 1 disease progression: relationship with virus load. Nakayama E.E., Meyer L., Iwamoto A., Persoz A., Nagai Y., Rouzioux C., Delfraissy J.F., Debre P., McIlroy D., Theodorou I. et al. J. Infect. Dis. 185:1183-1186(2002) · Mapped (8) |
| Effects of CCR5-Delta32, CCR2-64I, and SDF-1 3'A alleles on HIV-1 disease progression: An international meta-analysis of individual-patient data. Ioannidis J.P., Rosenberg P.S., Goedert J.J., Ashton L.J., Benfield T.L., Buchbinder S.P., Coutinho R.A., Eugen-Olsen J., Gallart T., Katzenstein T.L. et al. Ann. Intern. Med. 135:782-795(2001) · Mapped (26) |
| CCR5 delta32 deletion and response to highly active antiretroviral therapy in HIV-1-infected patients. Guerin S., Meyer L., Theodorou I., Boufassa F., Magierowska M., Goujard C., Rouzioux C., Debre P., Delfraissy J.F. AIDS 14:2788-2790(2000) · Mapped (22) |
| Rapid progression to AIDS in HIV+ individuals with a structural variant of the chemokine receptor CX3CR1. Faure S., Meyer L., Costagliola D., Vaneensberghe C., Genin E., Autran B., Delfraissy J.-F., McDermott D.H., Murphy P.M., Debre P. et al. Science 287:2274-2277(2000) · UniProtKB (1) |